Kathryn Moore
From Wikipedia, the free encyclopedia
Fellow of the National Academy of Sciences
American Heart Association Distinguished Scientist AwardKathryn J. Moore | |
|---|---|
 | |
| Alma mater | McGill University |
| Known for | Atherosclerosis |
| Awards | National Institutes of Health R35 Outstanding Investigator Award
Fellow of the National Academy of Sciences American Heart Association Distinguished Scientist Award |
| Scientific career | |
| Fields | Atherosclerosis and Inflammation |
| Institutions | Harvard Medical School New York University Langone Medical Center |
| Thesis | Regulation of macrophage function during intracellular infection with Leishmania donovani. (1994) |
| Doctoral advisor | Greg Matlashewski |
| Website | https://kathrynmoorelab.com/ |
Kathryn J. Moore is a Canadian-born American biomedical scientist and cell biologist. She is the Jean and David Blechman Professor of Cardiology and the founding director of the Cardiovascular Research Center[1] at the New York University Grossman School of Medicine. Moore's research considers the pathogenesis of atherosclerosis, with a focus on the identification of novel therapeutic targets. She was elected Fellow of the National Academy of Sciences in 2021.[2]
Kathryn Moore was born in Montreal, Quebec, Canada, where she attended McGill University. Moore studied microbiology, receiving her BSc (Distinction) from McGill University in 1989. She remained there for graduate studies, studying mechanisms by which the intracellular pathogen Leishmania donovani subverts macrophage microbicidal functions,[3][4][5] under the Canadian immunologist Greg Matlashewski. Moore was awarded her PhD in parasitology in 1994.[6]
